*Assessment of the Methodological Quality*

The methodological quality was assessed for each redox biomarker in multiple sclerosis.



**Table A1.** *Cont.*

**Table A2.** Risk of bias was assessed according to the criteria of availability of meta-analysis or systematic review, study types, and with or without conflicting results, to judge evidence levels of high risk, low risk, or unclear.

